China Universal Asset Management Company’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $549K | Buy |
34,329
+258
| +0.8% | +$4.13K | 0.05% | 233 |
|
|
2025
Q1 | $582K | Buy |
34,071
+2,947
| +9% | +$50.4K | 0.05% | 238 |
|
|
2024
Q4 | $771K | Buy |
31,124
+2,973
| +11% | +$73.6K | 0.07% | 197 |
|
|
2024
Q3 | $803K | Buy |
28,151
+10,991
| +64% | +$313K | 0.09% | 158 |
|
|
2024
Q2 | $453K | Sell |
17,160
-10,776
| -39% | -$284K | 0.06% | 154 |
|
|
2024
Q1 | $903K | Buy |
27,936
+11,202
| +67% | +$362K | 0.11% | 135 |
|
|
2023
Q4 | $705K | Buy |
16,734
+13,374
| +398% | +$563K | 0.14% | 128 |
|
|
2023
Q3 | $129K | Buy |
3,360
+1,651
| +97% | +$63.4K | 0.04% | 177 |
|
|
2023
Q2 | $32.4K | Sell |
1,709
-55
| -3% | -$1.04K | 0.01% | 232 |
|
|
2023
Q1 | $27.4K | Buy |
1,764
+452
| +34% | +$7.01K | 0.01% | 191 |
|
|
2022
Q4 | $23.3K | Buy |
1,312
+220
| +20% | +$3.91K | 0.01% | 166 |
|
|
2022
Q3 | $6K | Buy |
+1,092
| New | +$6K | ﹤0.01% | 253 |
|